Basic information Safety Related Supplier

CAL-101

Basic information Safety Related Supplier
CAL-101 Basic information
CAL-101 Usage And Synthesis
  • IndicationsAmong the large groups of structural diverse lipid kinase inhibitors, especially against PI3Ks, idelalisib (Zydelig(R), Gilead Sciences) is the only inhibitor approved by FDA for the treatment of patients with relapsed chronic lymphocytic leukemia in combination with rituximab and patients with relapsed follicular B-cell non-Hodgkin lymphoma or small lymphocytic lymphoma.
CAL-101(1146702-54-6)Related Product Information
CAL-101SupplierMore
  • Company Name:SpringPharma Tech Co.,Ltd Gold
  • Tel:+86-25-68710855/ +86-25-68710897
  • Email:sales@springpharma.net
  •  
  • Company Name:Artis Chemistry (Shanghai) Co. Ltd.
  • Tel:86-21-60936353
  • Email:synthesis@artis-chem.com
  •  
  • Company Name:S.Z. PhyStandard Bio-Tech. Co., Ltd.
  • Tel:17727448752,0755-83725681-603
  • Email:rex.liu@phystandard.com;tom.liu@phystandard.com
  •  
  • Company Name:NCE Biomedical Co.,Ltd.
  • Tel:4000-027-021 |24 hour enquiry :+86-13986109188 |English:+86-15623472865 |Japanese:+81-08033611988
  • Email:sales@ncebiomed.com
  •  
  • Company Name:Jinan XuanDe Chemical Co., Ltd.
  • Tel:18866891188 0531-88803958-
  • Email:xuandechem@126.com
  •